Participants must be adults aged 1875 with moderately to severely active UC confirmed by endoscopy and histology, having at least 15 cm disease extent from anal verge, modified MS of 59 points with MES of at least 2, and inadequate response or intolerance to prior treatments including corticosteroids, immunomodulators, or advanced therapies, while excluding those with CD, toxic megacolon, prior vedolizumab exposure, or contraindicated medications, with the study completing primary outcomes in October 2025 and final completion estimated for February 2027
Wegovy prescription with one of our board-certified doctors
Currency risk is an additional consideration for companies generating revenues in multiple geographies with significant exposure to the euro, yen, and renminbi relative to the U.S
Son muchas las empresas que actualmente comercializan suplementos con L-Carnitina en el mercado, pero no todas son fiables, pues el proceso de aislamiento de la L-Carnitina es costoso